
About GeseDNA
GeseDNA is a Healthcare company based in Beijing (China) founded in 2014. Gene detection tools and DNA interpretation services are provided. Its website gesedna.com draws about 92 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its competitors include CircleDNA, Xbiome and NeoCura; 3 of its 3 listed competitors have raised funding.
Company details
Provider of gene detection and interpretation tool. The company has developed a data management system that helps to analyze ancestry raw data, interpret DNA and behavior, combine innate trends and current status assessments, and provide solutions by optimizing lifestyles.
- Headquarters Beijing, China
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website gesedna.com
- Social LinkedIn
- Investors
Funding Insights of GeseDNA
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of GeseDNA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | Seed | β | β |
1 investors in total: 1 institutional.
Investors in GeseDNA
GeseDNA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Idaxiang.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Operates as an online platform for diverse content delivery. | 2013 | idaxiang.org | Beijing, China |
Investor details for GeseDNA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of GeseDNA
2 dated milestones of GeseDNA across 4 years, from founding to its latest funding, stage changes and deals.
- Founded GeseDNA is founded.
- Funding First funding round.
Competitors of GeseDNA
GeseDNA has 3 listed competitors in our database, 3 of them funded. They include CircleDNA, Xbiome and NeoCura.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| circledna.com | 2014 | Hong Kong, China | $15M | Internet-first platform for genetic diagnostics is provided. | ||
| xbiome.com | 2017 | Shenzhen, China | $107.5M | AI-enabled bioinformatics platform for microbiome-based drug discovery is developed. | ||
| neocura.net | 2017 | Changping, China | $38.19M | AI-enabled platforms for tumor diagnosis and immunotherapy are developed. |
Detailed competitors of GeseDNA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GeseDNA
The website of GeseDNA (gesedna.com) receives about 92K visits a month.
- Monthly visits92K
▼ 8.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GeseDNA
GeseDNA was founded in 2014 and raised its 1st funding round 4 years after it was founded.
GeseDNA is headquartered in Beijing, China.
Provider of gene detection and interpretation tool. The company has developed a data management system that helps to analyze ancestry raw data, interpret DNA and behavior, combine innate trends and current status assessments, and provide solutions by optimizing lifestyles.
GeseDNA has 1 investor. Key investors include Idaxiang.